- Home
- FBRX vs OPRX Comparison
FBRX vs OPRX Comparison
Compare FBRX & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- OPRX
- Stock Information
- Founded
- FBRX N/A
- OPRX 2006
- Country
- FBRX United States
- OPRX United States
- Employees
- FBRX N/A
- OPRX N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- FBRX Health Care
- OPRX Consumer Discretionary
- Exchange
- FBRX Nasdaq
- OPRX Nasdaq
- Market Cap
- FBRX 125.9M
- OPRX 111.2M
- IPO Year
- FBRX N/A
- OPRX N/A
- Fundamental
- Price
- FBRX $15.35
- OPRX $5.62
- Analyst Decision
- FBRX Strong Buy
- OPRX Buy
- Analyst Count
- FBRX 4
- OPRX 8
- Target Price
- FBRX $77.58
- OPRX $9.06
- AVG Volume (30 Days)
- FBRX 61.1K
- OPRX 255.6K
- Earning Date
- FBRX 11-14-2024
- OPRX 11-13-2024
- Dividend Yield
- FBRX N/A
- OPRX N/A
- EPS Growth
- FBRX N/A
- OPRX N/A
- EPS
- FBRX N/A
- OPRX N/A
- Revenue
- FBRX N/A
- OPRX $88,179,506.00
- Revenue This Year
- FBRX N/A
- OPRX $28.59
- Revenue Next Year
- FBRX N/A
- OPRX $10.52
- P/E Ratio
- FBRX N/A
- OPRX N/A
- Revenue Growth
- FBRX N/A
- OPRX 40.40
- 52 Week Low
- FBRX $4.11
- OPRX $3.78
- 52 Week High
- FBRX $28.68
- OPRX $16.65
- Technical
- Relative Strength Index (RSI)
- FBRX 41.80
- OPRX 55.97
- Support Level
- FBRX $14.66
- OPRX $4.72
- Resistance Level
- FBRX $17.00
- OPRX $5.14
- Average True Range (ATR)
- FBRX 2.62
- OPRX 0.44
- MACD
- FBRX -0.86
- OPRX 0.02
- Stochastic Oscillator
- FBRX 13.83
- OPRX 61.96
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.